Repository logo
 

RISC-mediated control of selected chromatin regulators stabilizes ground state pluripotency of mouse embryonic stem cells.

Published version
Peer-reviewed

Repository DOI


Type

Article

Change log

Authors

Luzi, E 
Ucciferri, N 
Bertacchi, M 

Abstract

BACKGROUND: Embryonic stem cells are intrinsically unstable and differentiate spontaneously if they are not shielded from external stimuli. Although the nature of such instability is still controversial, growing evidence suggests that protein translation control may play a crucial role. RESULTS: We performed an integrated analysis of RNA and proteins at the transition between naïve embryonic stem cells and cells primed to differentiate. During this transition, mRNAs coding for chromatin regulators are specifically released from translational inhibition mediated by RNA-induced silencing complex (RISC). This suggests that, prior to differentiation, the propensity of embryonic stem cells to change their epigenetic status is hampered by RNA interference. The expression of these chromatin regulators is reinstated following acute inactivation of RISC and it correlates with loss of stemness markers and activation of early cell differentiation markers in treated embryonic stem cells. CONCLUSIONS: We propose that RISC-mediated inhibition of specific sets of chromatin regulators is a primary mechanism for preserving embryonic stem cell pluripotency while inhibiting the onset of embryonic developmental programs.

Description

Keywords

Animals, Carboxypeptidases, Cell Differentiation, Chromatin, Embryonic Development, Epigenesis, Genetic, Gene Expression Regulation, Developmental, Mice, Mouse Embryonic Stem Cells, Pluripotent Stem Cells, Protein Biosynthesis, RNA, Messenger, RNA-Induced Silencing Complex

Journal Title

Genome Biology

Conference Name

Journal ISSN

1474-7596
1474-760X

Volume Title

17

Publisher

Springer Nature
Sponsorship
Cancer Research UK (C14303/A17197)
Wellcome Trust (092096/Z/10/Z)
Cancer Research Uk (None)
This work was funded by: FIRB RBAP10L8TY (MIUR), Fondazione Roma and PAINCAGE FP7 Collaborative Project number 603191 (RB,MD); Flagship Project InterOmics PB.05 and MIUR-PRIN-2012 (FC); Wellcome Trust Core Grant reference 092096 and Cancer Research UK Grant Reference C6946/A14492 (LP); CRUK-Cambridge Institute Core Grant reference C14303/A17197 (DB).